Gastric sleeve surgery — formally known as sleeve gastrectomy — is one of the most commonly performed bariatric procedures in the UK, offering significant and sustained weight loss for eligible patients. Public figures discussing their experiences with weight loss surgery have helped raise awareness and reduce stigma around bariatric care. This article explains how sleeve gastrectomy works, who qualifies under NHS criteria, what to expect before and after the procedure, and the long-term lifestyle commitment required. Whether you are exploring options for yourself or seeking reliable clinical information, this guide draws on NHS, NICE, and BOMSS guidance to help you make an informed decision.

What Is Gastric Sleeve Surgery and How Does It Work?

Gastric sleeve surgery removes 75–80% of the stomach laparoscopically, creating a small sleeve-shaped pouch that restricts intake and reduces ghrelin levels, lowering appetite. It is permanent and irreversible.

Have any more questions about this? Message our pharmaceutical team to get more info →

Gastric sleeve surgery, formally known as sleeve gastrectomy, is a type of bariatric (weight loss) surgery in which approximately 75–80% of the stomach is surgically removed, leaving a narrow, sleeve-shaped pouch roughly the size of a banana. This significantly reduces the stomach's capacity, meaning patients feel full much sooner after eating smaller portions. The exact proportion removed and operative duration vary depending on the individual patient and surgical centre.

Beyond simple restriction, the procedure also has important hormonal effects. The portion of the stomach removed contains the majority of cells that produce ghrelin — often called the 'hunger hormone' — so ghrelin levels fall after surgery, helping to reduce appetite. The procedure also alters levels of other gut hormones, including GLP-1 and PYY, which further suppress appetite and contribute to improvements in blood glucose control. These hormonal changes are an important part of why sleeve gastrectomy can be effective, though the degree of appetite suppression varies between individuals.

It is worth noting that pre-existing gastro-oesophageal reflux disease (GORD) can worsen after sleeve gastrectomy. This is an important consideration during multidisciplinary team (MDT) decision-making, and patients with significant reflux may be better suited to an alternative procedure such as gastric bypass.

The operation is typically performed laparoscopically (keyhole surgery) under general anaesthesia, usually taking between 60 and 90 minutes. Unlike gastric bypass surgery, sleeve gastrectomy does not reroute the digestive tract, which gives it a different risk profile. It is considered a permanent, irreversible intervention and is only recommended after thorough clinical assessment and when other weight management strategies have not achieved sufficient results.

Public interest in bariatric procedures has grown in recent years, and increased media coverage has helped reduce stigma and encouraged more people to seek information about clinically appropriate weight management options. For reliable information, patients are encouraged to consult NHS and NICE resources directly.

Who Is Eligible for Weight Loss Surgery on the NHS?

NHS eligibility follows NICE guideline CG189, requiring a BMI of 40 kg/m² or above, or 35–39.9 kg/m² with a significant obesity-related condition, after completing a Tier 3 weight management programme.

Access to bariatric surgery on the NHS is governed by criteria set out by the National Institute for Health and Care Excellence (NICE). According to NICE guideline CG189 (Obesity: identification, assessment and management), weight loss surgery may be considered for adults who meet specific clinical thresholds:

• BMI of 40 kg/m² or above, or

• BMI between 35–39.9 kg/m² with a significant obesity-related health condition such as type 2 diabetes, hypertension, or obstructive sleep apnoea

• In some cases, individuals with a BMI of 30–34.9 kg/m² with recent-onset type 2 diabetes may also be considered

NICE also notes that lower BMI thresholds may be appropriate when assessing risk and eligibility for people from some ethnic groups, in whom the health risks associated with excess weight can occur at a lower BMI. Clinicians should take this into account during assessment.

NICE recommends that surgery should be considered only when the patient has been unable to achieve or maintain clinically beneficial weight loss through non-surgical interventions. In NHS practice, this typically means completing a Tier 3 specialist weight management programme — a structured, multidisciplinary service involving dietary, physical activity, behavioural, and pharmacological support — before referral to a Tier 4 bariatric surgical service. Patients should discuss this pathway with their GP as a first step.

Eligibility is not determined by BMI alone. Patients must also be fit for surgery and anaesthesia, be committed to long-term dietary and lifestyle changes, and have received a comprehensive multidisciplinary assessment. This typically involves input from a dietitian, psychologist, specialist nurse, and bariatric surgeon, in line with NICE quality standard QS127.

NHS availability varies by Integrated Care Board (ICB) area, and waiting times can be lengthy. Some patients choose to pursue surgery privately, where eligibility criteria may differ slightly, though reputable private providers generally follow NICE-aligned standards.

What to Expect Before, During and After Gastric Sleeve Surgery

Patients follow a pre-operative liver-reduction diet, undergo multidisciplinary assessment, and progress through staged dietary phases post-surgery, spending one to two nights in hospital after the 60–90 minute procedure.

Preparation for gastric sleeve surgery is a structured process that typically begins several months before the operation. Patients are usually required to follow a low-calorie liver-reduction diet for two to four weeks prior to surgery. This helps shrink the liver, which overlies the stomach, making the procedure safer and technically easier for the surgical team.

During the pre-operative period, patients undergo a range of assessments including blood tests, cardiovascular evaluation, nutritional screening, and psychological review. Smoking cessation is strongly advised, as smoking significantly increases the risk of surgical complications and impairs healing. Patients should also undergo a medication review with their GP or pharmacist before surgery. This is particularly important for glucose-lowering medicines (such as insulin or sulphonylureas), which may need to be adjusted or stopped to reduce the risk of hypoglycaemia after the operation, and for antihypertensives, which may require dose reduction as blood pressure improves with weight loss.

Patients should also discuss contraception and pregnancy planning with their clinical team before surgery. It is strongly recommended to avoid pregnancy for at least 12–18 months after bariatric surgery, as rapid weight loss during this period can affect foetal development. Reliable contraception should be in place before the operation; note that oral contraceptive pills may be less reliably absorbed in the early post-operative period, so alternative methods should be discussed.

The surgery itself is performed under general anaesthesia. The surgeon makes several small incisions in the abdomen and uses a laparoscope and specialised instruments to remove the majority of the stomach. A surgical stapler is used to create the sleeve shape, and the procedure is typically completed within 60–90 minutes. Most patients spend one to two nights in hospital.

Early mobilisation, breathing exercises, and prescribed VTE (venous thromboembolism) prophylaxis — such as compression stockings and low-molecular-weight heparin injections — are standard components of post-operative recovery and help reduce the risk of deep vein thrombosis (DVT) and pulmonary embolism.

In the immediate post-operative period, patients follow a staged dietary progression guided by their bariatric team. A typical UK pathway is:

• Weeks 1–2: Full liquids, including protein-containing drinks, to support healing and meet protein and hydration targets

• Weeks 3–4: Pureed and smooth foods

• Weeks 5–6: Soft, moist foods

• Week 7 onwards: Gradual reintroduction of solid foods

The exact progression varies by centre and individual tolerance; patients should always follow the specific guidance provided by their own bariatric team. Pain is usually manageable with prescribed analgesia, and most patients return to light activities within two to four weeks. Regular follow-up appointments with the bariatric team are essential during recovery to monitor nutritional status and support adherence to dietary guidelines.

Weight Loss Results and Long-Term Outcomes After Sleeve Gastrectomy

Sleeve gastrectomy typically produces 50–60% excess body weight loss within 12–18 months, with improvements in diabetes, hypertension, and sleep apnoea, though long-term success requires sustained lifestyle changes.

Gastric sleeve surgery is associated with significant and sustained weight loss for the majority of patients. Based on UK and international data, individuals can typically expect to lose approximately 50–60% of their excess body weight (EWL), equivalent to around 20–25% of total body weight, within the first 12 to 18 months following surgery. Individual results vary considerably depending on starting weight, adherence to dietary and lifestyle changes, and other health factors.

Beyond weight reduction, sleeve gastrectomy is associated with meaningful improvements in obesity-related comorbidities. Clinical evidence consistently demonstrates improvements in:

• Type 2 diabetes — with remission achieved in a significant proportion of patients, particularly those with shorter duration of disease

• Hypertension and cardiovascular risk factors

• Obstructive sleep apnoea

• Joint pain and mobility

• Mental health and quality of life

Long-term outcomes depend heavily on adherence to dietary and lifestyle changes. Research suggests that some patients may experience weight regain after three to five years, particularly if behavioural changes are not maintained. This reflects the complex, multifactorial nature of obesity as a chronic condition rather than a failure of the surgery itself.

Comparative studies suggest that gastric bypass surgery may produce slightly greater weight loss and more durable diabetes remission than sleeve gastrectomy, though the sleeve is generally associated with a lower risk of nutritional deficiencies and dumping syndrome. Gastric bypass is also typically preferred for patients with significant pre-existing GORD. The choice between procedures should be made collaboratively between the patient and their MDT, taking into account individual health status, preferences, and risk factors.

Regular long-term follow-up, including annual blood tests to monitor nutritional markers, remains an essential component of sustained success after bariatric surgery and is recommended by both NICE and the British Obesity and Metabolic Surgery Society (BOMSS).

Risks, Complications and Safety Considerations for Bariatric Surgery

Key risks include staple line leak (~1%), GORD worsening, nutritional deficiencies, and DVT; lifelong supplementation and annual blood tests are essential, with a 30-day mortality of approximately 0.1% in UK specialist centres.

As with any major surgical procedure, gastric sleeve surgery carries risks that patients must understand and accept prior to consenting to the operation. NICE quality standard QS127 emphasises that surgery should only be performed in specialist bariatric centres with appropriate multidisciplinary support and audit processes in place.

Short-term risks include:

• Bleeding or haematoma

• Staple line leak — a serious but uncommon complication; UK registry data suggest rates of approximately 1% in specialist centres

• Infection

• Deep vein thrombosis (DVT) or pulmonary embolism

• Adverse reactions to anaesthesia

Longer-term complications may include:

• Gastro-oesophageal reflux disease (GORD) — notably more common after sleeve gastrectomy than gastric bypass, and may be new or worsened

• Nutritional deficiencies, particularly in vitamin B12, iron, vitamin D, folate, and calcium

• Stricture or narrowing of the sleeve

• Weight regain

Nutritional supplementation is required lifelong following bariatric surgery. In line with BOMSS guidance, patients are typically advised to take a complete bariatric multivitamin–mineral supplement meeting BOMSS minimum standards, together with calcium and vitamin D supplementation. Additional iron, vitamin B12, or other supplements may be required based on blood test results. If persistent vomiting occurs after surgery, urgent thiamine (vitamin B1) supplementation should be sought, as deficiency can develop rapidly and cause serious neurological complications.

Annual blood tests are recommended by NICE and BOMSS to monitor nutritional status. A standard panel typically includes: full blood count (FBC), urea and electrolytes (U&Es), liver function tests (LFTs), ferritin and iron studies, folate, vitamin B12, vitamin D, calcium, and parathyroid hormone (PTH). HbA1c and lipids should also be checked as clinically indicated. These tests should be arranged through the patient's GP or bariatric team.

Seek urgent medical attention — including calling 999 or attending an emergency department — if any of the following occur after surgery:

• Severe or worsening abdominal pain

• Persistent vomiting

• Fever or signs of infection

• Sudden chest pain or difficulty breathing

• Coughing up blood

• Unilateral leg swelling, redness, or calf pain

These symptoms may indicate a staple line leak, pulmonary embolism, DVT, or other serious complication requiring prompt intervention.

The overall 30-day mortality risk associated with sleeve gastrectomy in UK specialist centres is approximately 0.1%, reflecting the importance of careful patient selection and specialist surgical care.

Patients who experience unexpected symptoms or side effects after surgery are encouraged to report these via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk), which allows patients and healthcare professionals to report suspected adverse reactions and medical device incidents to support ongoing safety monitoring.

Support, Lifestyle Changes and Follow-Up Care After Surgery

Long-term success requires dietary adherence, at least 150 minutes of weekly aerobic activity, lifelong supplementation, regular clinic appointments, and annual blood tests, supported by dietetic and psychological input.

Gastric sleeve surgery is a powerful tool, but it is not a standalone solution. Long-term success depends on a sustained commitment to lifestyle modification, and patients are strongly encouraged to engage with the full spectrum of post-operative support available to them.

Dietary changes are fundamental. Patients must learn to eat slowly, chew thoroughly, avoid drinking fluids with meals, and prioritise protein-rich foods. Portion sizes remain small permanently, and high-calorie, nutrient-poor foods should be minimised. Working with a registered dietitian with bariatric expertise is strongly recommended both before and after surgery.

Physical activity plays an equally important role. Patients are typically advised to begin with gentle walking in the early post-operative weeks, gradually increasing to at least 150 minutes of moderate-intensity aerobic activity per week, in line with NHS physical activity guidelines for adults. Muscle-strengthening activities on at least two days per week are also recommended to support lean muscle mass and long-term weight maintenance. Exercise supports cardiovascular health and psychological wellbeing.

Alcohol should be approached with caution after bariatric surgery. Alcohol is absorbed more rapidly following sleeve gastrectomy, meaning smaller amounts can have a greater effect. There is also an increased risk of alcohol misuse developing after bariatric surgery. Patients should discuss alcohol intake with their bariatric team.

Medication review is important not only before surgery but also in the longer term. Some modified-release or enteric-coated formulations may be less reliably absorbed after bariatric surgery. Patients should ask their GP or pharmacist to review all medicines and consider whether formulations need to be changed.

Psychological support is a recognised component of comprehensive bariatric care. Some patients experience emotional challenges related to changes in body image, relationships, or their relationship with food. Access to counselling or cognitive behavioural therapy (CBT) can be beneficial, and patients should not hesitate to discuss mental health concerns with their GP or bariatric team.

Follow-up care typically includes:

• Regular clinic appointments at 6 weeks, 3 months, 6 months, and 12 months post-surgery, then annually

• Annual blood tests to monitor nutritional markers (see the Risks and Complications section for the recommended panel)

• Ongoing dietetic support

• Access to bariatric support groups, which many patients find invaluable for motivation and shared experience

Patients who feel their weight loss has stalled, who are experiencing nutritional symptoms, or who have concerns about their progress should contact their GP or bariatric team promptly rather than waiting for a scheduled appointment. Further information is available from the NHS (nhs.uk), NICE (nice.org.uk), and BOMSS (bomss.org.uk).

Frequently Asked Questions